GlassScriptPhysician profile
Henry Carson Jackson
NPI 1558624866
$5,442.06
in general payments reported to CMS, 2019-2025
47 companies · $641 in 2025
The $641 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $847 · 2020: $695 · 2021: $702 · 2022: $790 · 2023: $898 · 2024: $870 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $797.89 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $769.79 | 2019-2025 | Farxiga, Airsupra, Fasenra |
| Novo Nordisk INC | $596.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $519.86 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $339.68 | 2019-2025 | Trintellix |
| Amarin Pharma, INC. | $329.86 | 2019-2022 | |
| Amgen INC. | $187.14 | 2019-2025 | Krystexxa, Otezla, Repatha |
| Pfizer INC. | $184.16 | 2019-2025 | |
| Abbvie INC. | $183.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $141.03 | 2019-2024 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Eisai INC. | $119.89 | 2020-2021 | |
| Exact Sciences Corporation | $108.35 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $101.23 | 2024-2025 | Venaseal |
| Abbott Laboratories | $95.65 | 2022-2024 | Proclaim |
| Astellas Pharma US INC | $78.50 | 2023-2024 | Veozah, Myrbetriq |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.